Cargando…
Regulatory aspects of biological medicines in Bosnia and Herzegovina
The use of the biological medicines, also called “biologics,” has contributed to the progress of the treatment of many chronic diseases, such as cancer, rheumatoid arthritis, Crohn’s disease, multiple sclerosis, and psoriasis. However, biologicals are expensive for healthcare systems in several coun...
Autores principales: | Tubić, Biljana, Jungić, Saša |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392977/ https://www.ncbi.nlm.nih.gov/pubmed/35460398 http://dx.doi.org/10.17305/bjbms.2021.6910 |
Ejemplares similares
-
Availability and accessibility of monoclonal antibodies in Bosnia and
Herzegovina: Findings and implications
por: Tubic, Biljana, et al.
Publicado: (2021) -
Controversy and Concerns in the Relationship of Medicine and the Media in Bosnia and Herzegovina
por: Hajdarevic, Braco, et al.
Publicado: (2010) -
Adverse drug reaction reporting and development of pharmacovigilance systems in Bosnia and Herzegovina, Croatia, Serbia, and Montenegro: a retrospective pharmacoepidemiological study
por: Glamočlija, Una, et al.
Publicado: (2018) -
What is the Future of Family Medicine in Bosnia and Herzegovina?
por: Zalihic, Amra, et al.
Publicado: (2020) -
Medical Law – Challenges in Bosnia and Herzegovina
por: Masic, Izet, et al.
Publicado: (2010)